| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |